与多种药物不耐症综合征相关的初级状动力障碍:一个病例报告
La Tunisie medicale
|August 8, 2023
概括
多种药物不耐症综合征涉及对多种药物的不良药物反应,而无免疫原因. 详细的病史对于诊断至关重要,特别是识别风险因素和警告信号.
科学领域:
- 临床免疫学 临床免疫学
- 儿科肺病学 儿科肺病学
背景情况:
- 多种药物不耐症综合征 (MDIS) 定义为对三种或更多种药物的不良药物反应,而无免疫机制.
- MDIS是一种独特的临床实体,与药物交叉反应性有所区别.
- 患有MDIS的症状范围从轻微的皮疹到严重的疾病,如带有乙酸的药物反应和全身症状 (DRESS).
研究的目的:
- 讨论多种药物不耐症综合征的诊断要素.
- 突出临床病史在诊断MDIS中的重要性.
主要方法:
- 一个8岁的孩子患有初级状动力障碍和支气管切除症的病例报告.
- 孩子出现了与多种药物不耐症综合征相一致的症状.
主要成果:
- 该案例说明了MDIS在患有潜在呼吸系统疾病的儿科患者的临床表现.
- 这一观察强调了诊断MDIS的挑战.
结论:
- 目前缺乏MDIS的验证诊断标准.
- 一个全面的病史,包括识别警告信号和危险因素,对于诊断MDIS至关重要.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...


